Evidence map›Paper›PMID 24399151›Full record

ArticleMucosal immunology2014

Follicular dendritic cell secreted protein FDC-SP controls IgA production.

S Hou, I Landego, N Jayachandran, A Miller, I W Gibson, C Ambrose, A J Marshall

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. History of IgA Nephropathy Mouse Models.Journal of clinical medicine · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

S HouDepartment of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
I LandegoDepartment of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
N JayachandranDepartment of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
A MillerDepartment of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada.
I W GibsonDepartment of Pathology, University of Manitoba, Winnipeg, Manitoba, Canada.
C AmbroseBiogen-Idec, Cambridge, Massachusetts, USA.
A J Marshall1] Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada [2] Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
University of Manitoba · CABiogen (United States) · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Follicular dendritic cell secreted protein (FDC-SP) is a secreted peptide predominantly expressed in mucosal tissues. We previously reported that FDC-SP transgenic mice have altered B-cell responses to systemic immunization; however, the role of FDC-SP in mucosal immunity is unknown. Here, we report that FDC-SP functions in regulating immunoglobulin A production. FDC-SP transgenic mice show decreased IgA levels in serum, saliva, and bronchoalveolar lavage fluid. Reciprocally, FDC-SP-deficient mice show significantly increased IgA levels in serum and intestinal lavage, associated with accumulation of IgA+ cells in blood, bone marrow, Peyer's patches, and lymph nodes. FDC-SP-deficient mice generated higher titers of antigen-specific IgA but normal IgG1 responses upon immunization. Purified FDC-SP transgenic B cells generated decreased IgA responses to transforming growth factor β (TGFβ)+interleukin 5 (IL5) stimulation. Consistent with a direct effect of FDC-SP on B cells, recombinant FDC-SP suppressed B-cell IgA production in vitro. Six- to 14-month-old FDC-SP-deficient mice show IgA deposition in kidney glomeruli, which was associated with proteinuria and pathology consistent with mild IgA nephropathy (IgAN). Our results demonstrate a novel biological activity of FDC-SP in controlling B-cell IgA production and identify FDC-SP-deficient mice as a novel mouse model of IgAN.

Indexed as

AnimalsAntibody FormationB-LymphocytesDisease Models, AnimalImmunoglobulin AImmunoglobulin IsotypesImmunomodulationKidney DiseasesMaleMice, KnockoutMice, TransgenicProteinsFDC secreted protein, mouseImmunoglobulin AImmunoglobulin IsotypesProteins

Identifiers

PMID24399151
OpenAlexW2066471768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.